Reducing the rate of guideline-discordant therapy for inpatients with community-acquired pneumonia

Background: Despite guidelines recommending shorter durations of therapy and empiric coverage of Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus (MRSA) only for patients with certain risk factors, optimizing therapy for community-acquired pneumonia (CAP) remains a challenge fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Hannan, Kellie Arensman, Frykman, Paul, Mathiowetz, Eric, Sathre, Jill, Yang, Nou Cheng, Jensen, Kelsey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Antibiotic Stewardship
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594197/
http://dx.doi.org/10.1017/ash.2023.244

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594197/
http://dx.doi.org/10.1017/ash.2023.244

Ejemplares similares